Tytuł pozycji:
Managed care after acute myocardial infarction (MC-AMI) improves prognosis in AMI survivors with pre-existing heart failure. A propensity score matching analysis of Polish nationwide program of comprehensive post-MI care
- Tytuł:
-
Managed care after acute myocardial infarction (MC-AMI) improves prognosis in AMI survivors with pre-existing heart failure. A propensity score matching analysis of Polish nationwide program of comprehensive post-MI care
- Autorzy:
-
Kalarus, Zbigniew
Gołba, Krzysztof
Gąsior, Zbigniew
Cieśla, Daniel
Milewski, Krzysztof
Rozentryt, Piotr
Gąsior, Mariusz
Mizia-Stec, Katarzyna
Jankowski, Piotr
Pączek, Piotr
Wita, Krystian
Wojakowski, Wojciech
Sikora, Jacek
Nessler, Jadwiga
Nowalany-Kozielska, Ewa
Niedziela, Jacek T.
Buszman, Piotr
- Data publikacji:
-
2022
- Słowa kluczowe:
-
acute myocardial infarction
managed care
survival
heart failure
- Język:
-
angielski
- ISBN, ISSN:
-
00229032
- Prawa:
-
http://creativecommons.org/licenses/by-nc-nd/4.0/legalcode.pl
Udzielam licencji. Uznanie autorstwa - Użycie niekomercyjne - Bez utworów zależnych 4.0 Międzynarodowa
- Linki:
-
https://journals.viamedica.pl/kardiologia_polska/article/view/88314  Link otwiera się w nowym oknie
- Dostawca treści:
-
Repozytorium Uniwersytetu Jagiellońskiego
-
Background: Despite improvement in acute myocardial infarction (AMI) treatment, post-discharge mortality remains high. The outcomes are supposed to be even worse in patients with post-MI heart failure (HF), as only a half of patients with newly diagnosed HF survive four years.Aims: The study aimed to analyze whether managed care after acute myocardial infarction (MC-AMI) is associated with better survival in AMI survivors with a pre-existing diagnosis of HF. Results: The study included 7228 patients with a pre-existing diagnosis of HF who survived the hospitalization for AMI in Poland between November 2017 and December 2020, of whom 2268 (31.4%) were referred for the MC-AMI program. The median follow-up was 1.5 (0.7–2.3) years. In the unmatched analysis, patients without MC-AMI had more than twice higher 12-month mortality (21.8% vs. 9.9%; P <0.01) than MC-AMI participants. The difference remained significant after propensity score matching (16,8% vs. 10.0%; P <0.01). In multivariable analysis, participation in MC-AMI was an independent factor of 12-month survival. MC-AMI participants had a lower stroke rate (1.5% vs. 3.0%; P <0.01) and fewer hospital admissions due to HF (22.9% vs. 27.6%; P <0.01). Conclusions: After propensity score matching, participation in MC-AMI was associated with lower rates of stroke, HF hospitalizations, and all-cause mortality in the 12-month follow-up and was an independent factor of 12-month survival in AMI survivors with pre-existing HF.